Zentek (CVE:ZEN) Stock Price Up 26.1% – Still a Buy?

Zentek Ltd. (CVE:ZENGet Free Report)’s stock price traded up 26.1% during trading on Thursday . The stock traded as high as C$0.92 and last traded at C$0.87. 336,524 shares were traded during trading, an increase of 408% from the average session volume of 66,271 shares. The stock had previously closed at C$0.69.

Zentek Stock Up 26.1%

The firm’s 50-day simple moving average is C$0.76 and its 200 day simple moving average is C$0.94. The company has a debt-to-equity ratio of 15.41, a quick ratio of 7.59 and a current ratio of 1.00. The stock has a market capitalization of C$93.56 million, a P/E ratio of -10.88 and a beta of 0.34.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

See Also

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.